Notre Dame Football Recruiting

Notre Dame Set to Host Another Brini

June 22, 2017

A year ago, 2017 Georgia signee Latavious Brini made his way to South Bend for Irish Invasion. Notre Dame will host 2019 athlete Montavious Brini on Thursday for a visit, and he is looking to see what his older brother saw last year.

“My brother loved Notre Dame when he visited last summer,” Brini told Irish Sports Daily. “He said he liked the academics and how the coaches conduct their business. He also said the players had a good bond.

“Notre Dame is a great place to be, and I want to come see it for myself.”

The Irish haven’t been in much contact with the 6-foot-1, 192-pounder but area recruiter Autry Denson is more than aware of the Temple commit.
“Coach Denson follows me on Twitter,” stated Brini. “We haven’t really had a conversation yet.”

Brini and his teammate, Mikel Jones, will also see and camp at other programs as they are on a Midwest swing.  

“We are going to see Louisville, Ohio State, and West Virginia too,” Brini said.

The trip to Columbus caught Brini’s eye, and the Mater Academy (Fla.) star enjoyed the coaching style by the Buckeyes staff.

“I loved it,” Brini stated. “The coaches were nice, and they got after it during the camp. They taught me some things I needed to know, and I can go work on them now.”

Brini holds offers from Florida Atlantic, Illinois, Louisville, Mississippi State, Syracuse, Tulane, and USC, but two schools are recruiting him the hardest.

“Temple and Louisville are the coaches I hear from the most,” explained Brini. “Most schools see me playing linebacker in college.”

The Florida native found a home at Temple, but he is doing his due diligence to make sure he found the right fit.

"Temple was the first school to believe in me, and that meant a lot to me,” said Brini. “I am looking at academics and where I would stand in the football program.”  

Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.